In this May 2020 photo provided by Eli Lilly, a researcher tests possible COVID-19 antibodies in a laboratory in Indianapolis. Antibodies are proteins the body makes when an infection occurs; they attach to a virus and help it be eliminated.
These drugs are believed to last for a month or more and could give quick, temporary immunity to people at high risk of infection, such as health workers and housemates of someone with COVID-19. If they proved effective and if a vaccine doesn’t materialize or protect as hoped, the drugs might eventually be considered for wider use, perhaps for teachers or other groups.
“Our goal is to get something out as soon as possible” and to have hundreds of thousands of doses ready by fall, said Lilly’s chief scientific officer, Dr. Daniel Skovronsky. Lilly is testing two different, single-antibody drugs — one with the Canadian company AbCellera and another with a Chinese company, Junshi Biosciences. In July, Junshi said no safety concerns emerged in 40 healthy people who tried it and that larger studies were getting underway.
FFS, Herd immunity will be established before anything else. Also everyone will be in contact the virus before to long, so just get on with life normally, I am bored with all the BS.
DON'T RUSH. The whole point of TESTING the potential vaccines is to insure that in six months, it doesn't become TOXIC, or manifest some other dangerous medical flaw. Coronavirus has proven to be a very uncertain virus. It needs PROPER study to insure its long term SAFETY.
Uh huh. Did you read this? 'Antibodies may do the opposite of what’s hoped and actually enhance the virus’s ability to get into cells or stimulate the immune system' In other words -- this sort of approach CAN KILL YOU. Careful with that axe, Eugene.
What? Hydroxychloroquine? 🤪
Canada Canada Latest News, Canada Canada Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: AP - 🏆 728. / 51 Read more »
Source: Forbes - 🏆 394. / 53 Read more »
Source: BusinessInsider - 🏆 729. / 51 Read more »